[1] NOOLVI M N, PATEL H M, BHARDWAJ V, et al. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent[J]. Eur J Med Chem, 2011, 46: 2327-2346. DOI:10.1016/j.ejmech.2011.03.015. [2] AL-RASHOOD S T, ABOLDAHAB I A, NAGI M N, et al. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs[J]. Bioorg Med Chem, 2006, 14: 8608-8621. DOI:10.1016/j.bmc.2006.08.030. [3] GOODWIN S, SMITH A F, HORNING E C. Alkaloids of Ochrosia elliptica labill[J]. J Am Chem Soc, 1959, 81: 1903-1908. DOI: 10.1021/ja01517a031. [4] JURET P, TANGUY A, GIRARD A, et al. Preliminary trial of 9-hydroxy-2-methyl ellipticinium(NSC 264-137)in advanced human cancers[J]. Eur J Cancer, 1978, 14: 205-206. DOI:10.1016/0014-2964(78)90180-9. [5] SELVAM P, CLERCP E D, PANNECOUQUE C. Design, synthesis, anti-HIV activity and cytotoxicity of novel schiff’s base of indeo[1,2-b] quinoxalin-11-one derivatives[J]. Int J Drug Des Discov, 2013, 4: 1017-1019. [6] ZARRANZ B, JASO A, ALDANA I, et al. Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives[J]. Bioorg Med Chem, 2004, 12: 3711-3721. DOI:10.1016/j.bmc.2004.04.013. [7] DALLAVALLE S, FERRARI A, BIASOTTI B, et al. Novel 7-oxyiminomethyl derivatives of camptothecin with potent in vitro and in vivo antitumor activity[J]. J Med Chem, 2001, 44: 3264-3674. DOI: 10.1021/jm0108092. [8] SHARMA V M, PRASANNA P, SESHU K V A, et al. Novel indolo[2,1-b] quinazoline analogus as cytostatic agent: synthesis, biological evaluation and structure-activity relationship[J]. Bioorg Med Chem Lett, 2002, 12: 2303-2307. DOI:10.1016/S0960-894X(02)00431-6. [9] TSENG C H, TZENG C C,YANG C L, et al. Synthesis and antiproliferative evaluation of certain indeno[1,2-c] quinoline derivatives. part 2[J]. J Med Chem, 2010, 53: 6164-6179. DOI: 10.1021/jm1005447. |